In the BioHarmony Drug Report Database

"Preview" Icon

Levocabastine

Livostin (levocabastine) is a small molecule pharmaceutical. Levocabastine was first approved as Livostin on 1993-11-10. It is used to treat allergic conjunctivitis in the USA. It is known to target neurotensin receptor type 2.

 

Trade Name

 

Livostin
 

Common Name

 

levocabastine
 

ChEMBL ID

 

CHEMBL1615438
 

Indication

 

allergic conjunctivitis
 

Drug Class

 

Antihistaminics (histamine-H1 receptor antagonists)

Image (chem structure or protein)

Levocabastine structure rendering